Yahoo
NasdaqGS - Delayed Quote USD

Balchem Corporation (BCPC)

161.52 -0.10 (-0.06%)
At close: May 1 at 4:00:01 PM EDT
161.52 0.00 (0.00%)
After hours: May 1 at 5:13:51 PM EDT
Trade Balchem on Coinbase
BCPC Q1 2026 earnings call
Replay the call for the latest insights.
Read transcript
Chart Range Bar
Loading chart for BCPC
  • Previous Close 161.62
  • Open 162.47
  • Bid 161.30 x 200
  • Ask 162.65 x 200
  • Day's Range 158.05 - 163.63
  • 52 Week Range 139.17 - 183.90
  • Volume 238,795
  • Avg. Volume 201,485
  • Market Cap (intraday) 5.19B
  • Beta (5Y Monthly) 0.95
  • PE Ratio (TTM) 33.10
  • EPS (TTM) 4.88
  • Earnings Date (est.) Jul 30, 2026
  • Forward Dividend & Yield 0.96 (0.55%)
  • Ex-Dividend Date Dec 23, 2025
  • 1y Target Est 200.50

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

www.balchem.com

1,352

Full Time Employees

December 31

Fiscal Year Ends

Performance Overview: BCPC

Trailing total returns as of 5/1/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BCPC
5.32%
S&P 500 (^GSPC)
5.62%

1-Year Return

BCPC
3.59%
S&P 500 (^GSPC)
29.01%

3-Year Return

BCPC
25.37%
S&P 500 (^GSPC)
73.47%

5-Year Return

BCPC
30.40%
S&P 500 (^GSPC)
72.92%

Earnings Trends: BCPC

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 270.71M
Earnings 42.99M

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

0
50M
100M
150M
200M
250M

Analyst Insights: BCPC

View More

Analyst Price Targets

163.00
200.50 Average
161.52 Current
234.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 2/24/2026
Analyst HC Wainwright & Co.
Rating Action Maintains
Rating Buy
Price Action Maintains
Price Target 190 -> 190

Statistics: BCPC

View More

Valuation Measures

Annual
As of 5/1/2026
  • Market Cap

    5.19B

  • Enterprise Value

    5.30B

  • Trailing P/E

    33.17

  • Forward P/E

    30.21

  • PEG Ratio (5yr expected)

    3.77

  • Price/Sales (ttm)

    4.96

  • Price/Book (mrq)

    4.04

  • Enterprise Value/Revenue

    5.01

  • Enterprise Value/EBITDA

    20.37

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.93%

  • Return on Assets (ttm)

    8.02%

  • Return on Equity (ttm)

    12.86%

  • Revenue (ttm)

    1.04B

  • Net Income Avi to Common (ttm)

    154.84M

  • Diluted EPS (ttm)

    4.88

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    74.57M

  • Total Debt/Equity (mrq)

    14.37%

  • Levered Free Cash Flow (ttm)

    136.12M

Compare To: BCPC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights: BCPC

Fair Value

161.52 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports: BCPC

View More
  • Raising target price to $195.00

    BALCHEM CORP has an Investment Rating of BUY; a target price of $195.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of High.

    Rating
    Price Target
  • What does Argus have to say about BCPC?

    BALCHEM CORP has an Investment Rating of BUY; a target price of $193.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of High.

    Rating
    Price Target
  • Raising target price to $193.00

    BALCHEM CORP has an Investment Rating of BUY; a target price of $193.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of High.

    Rating
    Price Target
  • Raising target price to $187.00

    BALCHEM CORP has an Investment Rating of BUY; a target price of $187.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of High.

    Rating
    Price Target

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: